Literature DB >> 14625527

Smallpox and bioterrorism: public-health responses.

Harry F Hull1, Richard Danila, Kristen Ehresmann.   

Abstract

There is great concern that smallpox could be used for bioterrorism. The disease has a high mortality rate and can be spread by aerosols, and immunity in the population is low. Although an initial release of smallpox could infect a large number of people, secondary spread would likely be slow because of the long incubation period and the close contact required for transmission. Hospital personnel and household contacts are at the greatest risk of becoming infected. An outbreak of smallpox will be controlled through surveillance, containment, vaccination, and isolation of cases-the strategy used to eradicate the disease globally in 1978. Pre-exposure vaccination is recommended for hospital personnel likely to be exposed to smallpox while caring for patients during an outbreak.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625527     DOI: 10.1016/S0022-2143(03)00144-6

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  4 in total

1.  The public acceptance of smallpox vaccination to fight bioterrorism in Japan: results of a large-scale opinion survey in Japan.

Authors:  Hajime Sato; Jun Tomio; Yoshiaki Tanaka; Emiko Iwasaki
Journal:  Environ Health Prev Med       Date:  2010-12-21       Impact factor: 3.674

Review 2.  Countermeasures and vaccination against terrorism using smallpox: pre-event and post-event smallpox vaccination and its contraindications.

Authors:  Hajime Sato
Journal:  Environ Health Prev Med       Date:  2010-12-21       Impact factor: 3.674

3.  Mathematical models of contact patterns between age groups for predicting the spread of infectious diseases.

Authors:  Sara Y Del Valle; J M Hyman; Nakul Chitnis
Journal:  Math Biosci Eng       Date:  2013 Oct-Dec       Impact factor: 2.080

4.  The Impact of Consumer Purchase Behavior Changes on the Business Model Design of Consumer Services Companies Over the Course of COVID-19.

Authors:  Hu Tao; Xin Sun; Xia Liu; Jinfang Tian; Di Zhang
Journal:  Front Psychol       Date:  2022-03-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.